Contributions: (published works or studies, conference presentations)
- Peer-reviewed Publications: Gubbins PO, Amsden JR. Drug-drug interactions of antifungal agents and implications for patient care. Expert Opinion on Pharmacotherapy 2005; 6:2231-43.Amsden JR, Warmack T, Gubbins PO. Zoonoses. In
- Schumock G, Brundage D, Chapman M et al, eds. Pharmacotherapy Self-Assessment Program 5th ed. Infectious Diseases. Kansas City, MO: American College of Clinical Pharmacy, 2005: 1-42Amsden JR, Warmack T, Gubbins PO. Tick Borne Bacterial, Rickettsial, Spirochetal, and Protozoal Infectious Diseases in the United States: A comprehensive review. Pharmacotherapy. 2005
- 25(2):191-210Slain D, Amsden JR, Khakoo RA, Fisher MA, Lalka D, Hobbs GR. Effect of High-Dose Vitamin C on the Steady-State Pharmacokinetics of the Protease Inhibitor Indinavir in Healthy Volunteers. Pharmacotherapy. 2005
- 25(2):165 -170Book Chapters Gubbins PO, McConnell SA, Amsden JR. Drug Interactions Associated with Antifungal Agents. Chapter 10, pgs.289-337. In: Piscitelli SC, Rodvold KA, Ed. Drug Interactions in Infectious Diseases 2nd ed, Humana Press, Totowa, NJ
Butler Assignment (classes or work duties)
- Infectious Diseases Pharmacotherapy